Hybrid Approach for the Treatment of Superior Vena Cava Syndrome Induced by Pacemaker

Pacemaker-induced superior vena cava syndrome (SVCS) is a rare but incapacitating adverse event that can occur years after implantation. Inasmuch as it is a rare disease, there is no consensus about its treatment. The most widely used option is balloon angioplasty and venous stent implantation, with...

Full description

Saved in:
Bibliographic Details
Published inThe Annals of thoracic surgery Vol. 104; no. 2; pp. e131 - e132
Main Authors Maseda Uriza, Ramón, Jurado-Román, Alfonso, Jimenez Díaz, Javier, Piqueras Flores, Jesús, Higuera Sobrino, Felipe, Oliva De Anquín, Enrique
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Pacemaker-induced superior vena cava syndrome (SVCS) is a rare but incapacitating adverse event that can occur years after implantation. Inasmuch as it is a rare disease, there is no consensus about its treatment. The most widely used option is balloon angioplasty and venous stent implantation, with preservation of the lead or previous extraction and subsequent reimplantation after the procedure, which is associated with new episodes of thrombosis. The epicardial implantation reduces the risk of thrombosis. We report a case of pacemaker-induced SVCS for which we used a hybrid approach for epicardial lead implantation and electrode extraction, balloon angioplasty, and stent implantation.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0003-4975
1552-6259
DOI:10.1016/j.athoracsur.2017.02.063